Related references
Note: Only part of the references are listed.Monocyte-derived macrophages contain persistent latent HIV reservoirs
Rebecca T. Veenhuis et al.
NATURE MICROBIOLOGY (2023)
Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy
Yuyang Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2023)
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
Jeffrey S. Miller et al.
NATURE MEDICINE (2022)
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
Thomas S. Uldrick et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Novel role of UHRF1 in the epigenetic repression of the latent HIV-1
Roxane Verdikt et al.
EBIOMEDICINE (2022)
HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells
Paula C. Soto et al.
PLOS ONE (2022)
Latency Reversal 2.0: Giving the Immune System a Seat at the Table
Vidisha Singh et al.
CURRENT HIV/AIDS REPORTS (2021)
Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4(+) T cells in vivo
Francesco R. Simonetti et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Clonal Expansion of Infected CD4+T Cells in People Living with HIV
John M. Coffin et al.
VIRUSES-BASEL (2021)
The Current Status of Latency Reversing Agents for HIV-1 Remission
Anthony Rodari et al.
ANNUAL REVIEW OF VIROLOGY, VOL 8 (2021)
Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
Cynthia L. Gay et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)
Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy
John M. Coffin et al.
PLOS PATHOGENS (2021)
Epigenetic Mechanisms of HIV-1 Persistence
Roxane Verdikt et al.
VACCINES (2021)
HIV persistence in subsets of CD4+T cells: 50 shades of reservoirs
Remi Fromentin et al.
SEMINARS IN IMMUNOLOGY (2021)
Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy
Jenny L. Anderson et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial
Sarah Fidler et al.
LANCET (2020)
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Christopher C. Nixon et al.
NATURE (2020)
Curing HIV: Seeking to Target and Clear Persistent Infection
David M. Margolis et al.
CELL (2020)
Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women
Mark D. Pankau et al.
PLOS PATHOGENS (2020)
Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection
Cynthia L. Gay et al.
SCIENTIFIC REPORTS (2020)
Senotherapeutics and HIV-1 Persistence
Matthew A. Szaniawski et al.
CURRENT HIV/AIDS REPORTS (2020)
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
Justin Harper et al.
NATURE MEDICINE (2020)
The multifaceted nature of HIV latency
Caroline Dufour et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
Eugene D. M. D. Kroon et al.
JOURNAL OF VIRUS ERADICATION (2020)
Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals
Sara Moron-Lopez et al.
PLOS PATHOGENS (2020)
Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo
Lars Pache et al.
CELL REPORTS MEDICINE (2020)
Anti-IL-7 receptor α monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study
Joanne Ellis et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy
Allen Ko et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)
The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate
Michael Bobardt et al.
PLOS ONE (2019)
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+individuals
Line K. Vibholm et al.
AIDS (2019)
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
Takuya Yamamoto et al.
SCIENTIFIC REPORTS (2019)
PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy
Elena Bekerman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations
Judith Grau-Exposito et al.
PLOS PATHOGENS (2019)
Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
Nilu Goonetilleke et al.
FRONTIERS IN IMMUNOLOGY (2019)
The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation
Melissa-Rose Abrahams et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Latency-Reversing Agents Induce Differential Responses in Distinct Memory CD4 T Cell Subsets in Individuals on Antiretroviral Therapy
Marion Pardons et al.
CELL REPORTS (2019)
TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremia
Gregory Q. Del Prete et al.
JCI INSIGHT (2019)
HIV latency is reversed by ACSS2-driven histone crotonylation
Guochun Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
HIV latency in isolated patient CD4(+) T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing
Steven A. Yukl et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy
So-Yon Lim et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
Erica N. Borducchi et al.
NATURE (2018)
Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
Nancie M. Archin et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy
Jenna B. Honeycutt et al.
NATURE MEDICINE (2017)
BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
Panpan Lu et al.
SCIENTIFIC REPORTS (2017)
Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants
Bonnie Hiener et al.
CELL REPORTS (2017)
The Molecular Basis for Human Immunodeficiency Virus Latency
Uri Mbonye et al.
Annual Review of Virology (2017)
The non-canonical NF-κB pathway in immunity and inflammation
Shao-Cong Sun
NATURE REVIEWS IMMUNOLOGY (2017)
HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy
Annie Gosselin et al.
AIDS (2017)
HIV reservoirs: what, where and how to target them
Melissa J. Churchill et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial
Christine Katlama et al.
AIDS (2016)
Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
Carolina Gutierrez et al.
AIDS (2016)
Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro
Jennifer M. Zerbato et al.
JOURNAL OF VIROLOGY (2016)
Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation
Peilin Li et al.
NATURE MEDICINE (2016)
Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo
Adam M. Spivak et al.
RETROVIROLOGY (2016)
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Remi Fromentin et al.
PLOS PATHOGENS (2016)
Establishment and stability of the latent HIV-1 DNA reservoir
Johanna Brodin et al.
ELIFE (2016)
Combined eff ect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
Steffen Leth et al.
LANCET HIV (2016)
In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation
Jessica Brogdon et al.
SCIENTIFIC REPORTS (2016)
Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma
Fiona Wightman et al.
AIDS (2015)
BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency
Lars Pache et al.
CELL HOST & MICROBE (2015)
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Amanda M. Crooks et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Viremic Relapse after HIV-1 Remission in a Perinatally Infected Child
Katherine Luzuriaga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S. Sogaard et al.
PLOS PATHOGENS (2015)
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
Julian H. Elliott et al.
LANCET HIV (2015)
A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
Adam M. Spivak et al.
CLINICAL INFECTIOUS DISEASES (2014)
Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4+ T Cells
Natalia Soriano-Sarabia et al.
JOURNAL OF VIROLOGY (2014)
HIV-1 persistence in CD4+ T cells with stem cell like properties
Maria J. Buzon et al.
NATURE MEDICINE (2014)
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Thor A. Wagner et al.
SCIENCE (2014)
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
F. Maldarelli et al.
SCIENCE (2014)
Transcriptional control of HIV latency: Cellular signaling pathways, epigenetics, happenstance and the hope for a cure
Uri Mbonye et al.
VIROLOGY (2014)
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H. Elliott et al.
PLOS PATHOGENS (2014)
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A. Rasmussen et al.
LANCET HIV (2014)
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
Daniela Boehm et al.
CELL CYCLE (2013)
Restrictions to HIV-1 replication in resting CD4+ T lymphocytes
Xiaoyu Pan et al.
CELL RESEARCH (2013)
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
Zichong Li et al.
NUCLEIC ACIDS RESEARCH (2013)
Comparison of HDAC inhibitors in clinical development Effect on HIV production in latently infected cells and T-cell activation
Thomas Aagaard Rasmussen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients
Sophie Bouchat et al.
AIDS (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir
Shay Matalon et al.
MOLECULAR MEDICINE (2011)
Homeostatic Proliferation Fails to Efficiently Reactivate HIV-1 Latently Infected Central Memory CD4+T Cells
Alberto Bosque et al.
PLOS PATHOGENS (2011)
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Tae-Wook Chun et al.
AIDS (2010)
Differences in HIV Burden and Immune Activation within the Gut of HIV-Positive Patients Receiving Suppressive Antiretroviral Therapy
Steven A. Yukl et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV-1 Tat: Its Dependence on Host Factors is Crystal Clear
Ivan D'Orso et al.
VIRUSES-BASEL (2010)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
CpG Methylation Controls Reactivation of HIV from Latency
Jana Blazkova et al.
PLOS PATHOGENS (2009)
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Steven E. Kauder et al.
PLOS PATHOGENS (2009)
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
Nancy M. Archin et al.
AIDS (2008)
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
Nathalie Sagot-Lerolle et al.
AIDS (2008)
Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough
Yefei Han et al.
CELL HOST & MICROBE (2008)
Transcriptional interference antagonizes proviral gene expression to promote HIV latency
Tina Lenasi et al.
CELL HOST & MICROBE (2008)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid
Janet D. Siliciano et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
G Lehrman et al.
LANCET (2005)
Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors
L Ylisastigui et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Prostratin antagonizes HIV latency by activating NF-κB
SA Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression
L Ylisastigui et al.
AIDS (2004)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection
TC Pierson et al.
JOURNAL OF VIROLOGY (2002)
Effect of latent human immunodeficiency virus infection on cell surface phenotype
DG Brooks et al.
JOURNAL OF VIROLOGY (2002)
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection
M Dybul et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1
JJ Coull et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
